Menu
Back to Journals » International Journal of Nanomedicine » Volume 12
Original Research
A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effects
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,448 | Dovepress* | 8,371+ | 1,446 | 9,817 | |
| PubMed Central* | 1,077 | 354 | 1,431 | ||
| Totals | 9,448 | 1,800 | 11,248 | ||
| *Since 20 March 2017 | |||||
View citations on PubMed Central and Google Scholar